Simplify Genomics
Focus: Simplify Genomics is an early-stage genomic reporting platform company focused on ophthalmology, founded in 2023 and headquartered in Solana Beach, California. The company operates as a public entity with minimal disclosed operational footprint.
Profile data last refreshed 2h ago · AI intelligence enriched 1w ago
Funding Stage
PUBLIC
Open Jobs
2
Should You Work at Simplify Genomics?
AI assessmentA high-risk, high-upside early biotech opportunity best suited for founders or infrastructure-builders willing to bet on unproven genomics platform in ophthalmology.
Why Work Here
- Perfect entry point to a genomics-focused startup with clean intellectual property and ophthalmology specialization in a high-growth precision medicine segment
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Simplify Genomics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.